Pilot study of cisplatin, ifosfamide and irinotecan (CPT-11) with granulocyte colony-stimulating factor support (CIC-regimen) in relapsed small-cell lung cancer
Fujita, A.; Takabatake, H.; Tagaki, S.; Sekine, K.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(5): 761-764
1998
ISSN/ISBN: 0385-0684 PMID: 9571978 Document Number: 497917
Document emailed within 1 workday
Related Documents
Palackdharry, C.S.; Krigel, R.L. 1994: Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 6-11Rosell, R.; Gómez-Codina, J.; Anton, A.; Sánchez, J.J.; Vadell, C. 1994: Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate Seminars in Oncology 21(1 Suppl 1: 48-53
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Gridelli, C.; Frontini, L.; Barletta, E.; Rossi, A.; Barzelloni, M.L.; Scognamiglio, F.; Guida, C.; Gatani, T.; Fiore, F.; De Bellis, M.; Marfella, A.; Manzione, L. 2000: Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature Anticancer Research 20(2b): 1077-1084
Yamashita, Y.; Nara, N.; Aoki, N. 1989: Antiproliferative and differentiative effect of granulocyte-macrophage colony-stimulating factor on a variant human small cell lung cancer cell line Cancer Research 49(19): 5334-5338
Tanaka, A.; Aragane, N.; Komiya, K.; Kawaura, F.; Fukuno, Y.; Hayashi, S. 2008: A pilot study of irinotecan hydrochloride(CPT-11)and cisplatin(CDDP)combination chemotherapy for previously treated non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(1): 49-53
Chang, J.M.; Johnson, G.R. 1991: Effects on spleen colony-forming unit self-renewal after retroviral-mediated gene transfer of multi-colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or granulocyte colony-stimulating factor Experimental Hematology 19(7): 602-607
Biggs, D.; Stadtmauer, E.; Mangan, P.; Edelstein, M.; Powlis, W.; Buzby, G.; Magee, D.; Sachs, B.; Silberstein, L. 1994: 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation of relapsed, responding non-Hodgkin's lymphoma with granulocyte colony stimulating factor support results in reliable hematopoietic recovery Progress in Clinical and Biological Research 389: 9-15
Sakashita, A.; Nakamaki, T.; Tsuruoka, N.; Honma, Y.; Hozumi, M. 1991: Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor, co-operates with retinoic acid on the induction of functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells Leukemia 5(1): 26-31
Shirinian, M.; Lee, J.S.; Dhingra, H.H.; Greenberg, J.; Hong, W.K. 1992: Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: final report Seminars in Oncology 19(6 Suppl. 12): 58-63
Charoentum, C.; Thongprasert, S.; Chewasakulyong, B.; Euathrongchit, J.; Sorraritchingchai, S.; Munprakan, S. 2007: Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer Journal of the Medical Association of Thailand 90(11): 2506-2512
Saiers, J.H.; Slavik, M. 1981: Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer Veterinary and Human Toxicology 23(Suppl 1): 12-14
Baldini, E.; Silvano, G.; Tibaldi, C.; Campoccia, S.; Cionini, L.; Conte, P. 2000: Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase Ii study Seminars in Oncology 27(1 Suppl 1: 28-32
Matsuda, E.; Okabe, K.; Tao, H.; Yamamoto, H.; Hirazawa, K.; Kobayashi, S.; Murakami, T.; Sugi, K. 2011: Clinical assessment of granulocyte colony-stimulating factor producing lung cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 64(6): 445-449
Abou-Mourad, Y.; Otrock, Z.K.; Makarem, J.A.; Kattan, J.G.; Farhat, F.S.; Jalloul, R.; Mokaddem, W.T.; Ghosen, M.G.; Taher, A.T.; Chehal, A.A.; Shamseddine, A.I. 2008: Docetaxel and irinotecan as first-line chemotherapy in patients with advanced non-small-cell lung cancer: a pilot study Le Journal Medical Libanais. Lebanese Medical Journal 56(1): 16-21
Teramachi, M.; Miyamoto, N.; Yamamoto, Y.; Sasaka, T.; Nakamura, T.; Kitamura, F. 1992: A case of large cell carcinoma of the lung which is suspected of producing granulocyte colony-stimulating factor Nihon Kyobu Shikkan Gakkai Zasshi 30(7): 1327-1332
Zinzani, P.L.; Martelli, M.; Tura, S.; Mandelli, F. 1993: Granulocyte colony stimulating factor (G-CSF) as adjunct therapy in relapsed-resistant high-grade non-Hodgkin's lymphoma Haematologica 78(1): 40-43
Hazar, V.; Ongun, H.; Yeşilipek, M.A.; Yeğin, O. 1999: Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome Turkish Journal of Pediatrics 41(1): 117-120
Soh, L.T.; Tan, E.H.; Ang, P.T. 1998: Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer Singapore Medical Journal 39(8): 357-358
Zhang, X-Ru.; Zhu, Y-Zhong.; Xiu, Q-Yu.; Han, F-Cai.; Liu, D-Qi.; Chu, D-Tong. 2006: Irinotecan plus cisplatin for the treatment of advanced non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 28(10): 777-779